Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Worth 2014 J Biol Chem

From Bioblast
Publications in the MiPMap
Worth AJ, Basu SS, Snyder NW, Mesaros C, Blair IA (2014) Inhibition of neuronal cell mitochondrial complex I with rotenone increases lipid β-oxidation, supporting acetyl-coenzyme A levels. J Biol Chem 289:26895-903. doi: 10.1074/jbc.M114.591354

» PMID: 25122772 Open Access

Worth AJ, Basu SS, Snyder NW, Mesaros C, Blair IA (2014) J Biol Chem

Abstract: Rotenone is a naturally occurring mitochondrial complex I inhibitor with a known association with parkinsonian phenotypes in both human populations and rodent models. Despite these findings, a clear mechanistic link between rotenone exposure and neuronal damage remains to be determined. Here, we report alterations to lipid metabolism in SH-SY5Y neuroblastoma cells exposed to rotenone. The absolute levels of acetyl-CoA were found to be maintained despite a significant decrease in glucose-derived acetyl-CoA. Furthermore, palmitoyl-CoA levels were maintained, whereas the levels of many of the medium-chain acyl-CoA species were significantly reduced. Additionally, using isotopologue analysis, we found that β-oxidation of fatty acids with varying chain lengths helped maintain acetyl-CoA levels. Rotenone also induced increased glutamine utilization for lipogenesis, in part through reductive carboxylation, as has been found previously in other cell types. Finally, palmitoylcarnitine levels were increased in response to rotenone, indicating an increase in fatty acid import. Taken together, these findings show that alterations to lipid and glutamine metabolism play an important compensatory role in response to complex I inhibition by rotenone.

Bioblast editor: Gnaiger E

Labels: Pathology: Neurodegenerative, Parkinson's 

Tissue;cell: Nervous system  Preparation: Intact cells  Enzyme: Complex I  Regulation: Inhibitor